Noom Med

What to know before you sign up

Noom Med is six programs behind one brand, and the number that matters is which one you are buying. The three GLP-1Rx tiers ($79, $129 and $149 to start, then $199, $249 and $299 a month billed quarterly) are all-inclusive: clinician, medication and the Noom app in one price, with no insurance required. Read the footnotes and the medication is compounded: Noom's own results claims for those tiers are drawn from "Noom Med users prescribed compounded GLP-1s", the Plus tier describes a drug that "activates both GLP-1 and GIP receptors", which is tirzepatide's mechanism, and the terms say compounded prescriptions can only be filled by a pharmacy partner on Noom's platform, which the pages do not name. Noom's program page says compounded medications are "not approved by the FDA or reviewed for quality, safety or efficacy." The Microdose tier is a low dose marketed to reduce side effects; Noom describes it as a "Low-dose GLP-1 designed to reduce observable side effects".

The brand-name track is the opposite shape: $39 to start, then $99 a month for the clinician and the app, with Wegovy, Zepbound or Ozempic billed on top at whatever your insurance or a cash program charges. Noom says it will work to maximize your coverage but does not describe prior authorization on the pages we read.

Two structural points from the terms. Noom is not your clinician: care comes from "outside clinical partners", and the one named, Your Big Picture Healthcare, appears only in the billing clause. And Noom Med is cash-pay unless you arrive through an employer or health plan; Noom is not enrolled with Medicare or Medicaid.